Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
If you have any queries or need any help, please contact us at [email protected]
N Engl J Med 385(10):896907
The midpoint of interest was 6 months after the application of the intervention, and the endpoint of interest was the actual endpoint in the included studies
[13] Treatment was given for 30 weeks or 56 weeks
Neurogastroenterology: Improving glucose tolerance via the gut-brain axis
The lead authors of the study are Mahesh Umapathysivam, MBBS, DPhil, an endocrinologist and clinical researcher at Adelaide University in Australia and a former trainee with Gloyn, and Elisa Araldi, PhD, associate professor of medicine and surgery at the University of Parma in Italy and a former trainee with Stoffel
US$ 25.45
US$ 25.43
US$ 21.52
US$ 20.09
